Rhythm Pharmaceuticals Inc (RYTM)
Healthcare
Biotechnology
102.80 $
+3.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Rhythm Pharmaceuticals Inc (RYTM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -44 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -41 | -29 | -29 | -41 | -29 | -25 | -19 | -40 | -23 | -27 | -25 | -44 | -120 | |
| 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 1.2 | |
| 8.9 | 8.6 | 8.7 | 7.8 | 10 | 11 | 11 | 13 | 16 | 19 | 19 | 23 | 77 | |
| 9.1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -7.3 | -1.6 | 8.9 | -2.2 | -2.1 | 4.7 | 10 | -7.9 | 4.5 | 3.1 | -0.7 | -17 | -10 | |
| 0.9 | 0.0 | 0.0 | 40 | 0.0 | 40 | 0.0 | 0.0 | 0.0 | 0.0 | 1.0 | 0.0 | 1.0 | |
| 48 | -95 | 23 | 30 | -8.6 | -91 | 21 | 25 | 54 | -246 | 30 | 57 | -105 | |
| – | – | – | – | – | 2.6 | – | – | 2.7 | 1.4 | 0.0 | – | – | |
| 0.3 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1.3 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1.0 | 73 | 2.4 | 4.2 | 146 | 2.5 | 38 | 32 | -0.9 | 189 | -2.9 | -5.4 | 180 | |
| 6.0 | -51 | -4.5 | -6.5 | 108 | -114 | 42 | 17 | 30 | -83 | 2.2 | 7.8 | -44 | |
| -42 | -29 | -29 | -81 | -29 | -25 | -19 | -40 | -23 | -27 | -26 | -44 | -120 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.